CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 44 enrolled
Drug / intervention
methylprednisolone acetate +1 moredrug
Likely dose
methylprednisolone acetate 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01652495
NCT01652495Phase 4Completed
CompareCT.gov

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to a Single Intrabursal Injection of Corticosteroids in Patients With Shoulder Calcific Tendinopathy

Istituto Ortopedico Rizzoli·interventional·Posted Jul 30, 2012·Updated Sep 1, 2014

In Brief

A Phase 4 clinical trial evaluating methylprednisolone acetate and Triamcinolone Acetonide for Tendinopathy and Adrenal Insufficiency. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy and effects on the hypothalamus-pituitary-adrenal axis of a single intrabursal injection of two different types of corticosteroids (methylprednisolone and triamcinolone) in patients with calcific shoulder tendinopathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTendinopathy, Adrenal Insufficiency
CountriesItaly
CollaboratorsAzienda Ospedaliera San Giovanni Battista

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2012
Enrollment StartMar 1, 2012
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.9 years ago

Interventions

methylprednisolone acetatedrug

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of methylprednisolone acetate

Triamcinolone Acetonidedrug

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of triamcinolone acetonide